Cohort studyindependent cross-checkabstract checked I-GRN-109 standard review
Unhealed gut in coeliac disease is linked to more lymphoma
Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study.
Overview
Lebwohl B et al.. Ann Intern Med 2013 · PMID 23922062 · DOI 10.7326/0003-4819-159-3-201308060-00006
Among 7625 Swedish coeliac patients, those whose gut had not healed had about twice the lymphoma risk of those whose gut had healed.
Does the study support the specific claim? No · Methodological quality: moderate
Plain-language summary
Study explained simply
- What did the researchers want to find out?
Link mucosal healing with lymphoma.
- How was the study done?
National cohort.
- How many people, animals or samples were studied?
7625 patients.
- What was actually found?
Persistent damage: higher lymphoma risk.
- How large was the observed effect?
HR 2.26.
- What do the results mean in everyday life?
Healing the gut matters.
- What are the study's limitations?
No diet data.
- What does it say about Elawady's specific claim?
Contradicts the safety of reintroducing gluten.
- Do the results apply to Germany and Europe?
High.
- What can explicitly not be concluded from this study?
Cannot prove gluten exposure caused the cancers.
Scientific in-depth review
1. Full reference
- Authors
- Lebwohl B et al.
- Journal
- Ann Intern Med
- Year
- 2013
- Identifier
- PMID 23922062 DOI 10.7326/0003-4819-159-3-201308060-00006 · PMC3788608
- Verification
- verified – PubMed efetch 2026-10-26; Crossref works API 2026-10-26
- Retracted
- no
- Corrections
- none
- Extent checked
- abstract only
- Conflicts of interest and funding
NIH grants; no conflicts stated in abstract
2. Research question
Is persistent villous atrophy on follow-up biopsy associated with lymphoproliferative malignancy in coeliac disease?
3. Study design and population
- Study design
- Cohort study – Population-based cohort (Swedish pathology registers)
- Population
Patients with coeliac disease who had a follow-up biopsy
- Country
Sweden
- Period
not stated in abstract
- Sample size
7625
- Inclusion and exclusion criteria
Coeliac disease with follow-up biopsy
4. Methods and endpoints
- Exposure / intervention
Persistent villous atrophy
- Comparator
Mucosal healing
- Endpoints
Lymphoproliferative malignancy (LPM)
- Statistical methods
Standardised incidence ratios; Cox regression
5. Actual results
- Results
3308 (43%) had persistent villous atrophy. LPM SIR vs general population 2.81 (2.10-3.67); persistent atrophy SIR 3.78 (2.71-5.12); mucosal healing SIR 1.50 (0.77-2.62). Persistent atrophy vs healing HR 2.26 (1.18-4.34). T-cell lymphoma HR 3.51 (0.75-16.34); B-cell HR 0.97 (0.21-4.49).
- Absolute risks
not reported in abstract (absolute numbers of cases not given)
- Authors' conclusion
Increased LPM risk in coeliac disease is associated with persistent villous atrophy.
6. Strengths
- Large population-based cohort
- Histology-based exposure
7. Weaknesses
- No dietary adherence data
- Observational; persistent atrophy may have causes other than gluten
8. Risk of bias
- Orienting tool
- ROBINS-E
- Type of assessment
- simplified assessment (abstract only)
- Full formal assessment
- no
- Overall risk of bias
- some concerns
- Rationale
Confounding and selection to follow-up biopsy possible.
9. Assessment of the statistical interpretation
HR CI log-symmetric (stats/C-GRN-03). Relative risks; absolute lymphoma risk remains low.
10. Relevance to the specific claim
Links ongoing mucosal damage (as caused by gluten exposure) with lymphoma risk.
11. Independent contrary findings
Adherence not measured.
12. Transferability to Germany and Europe
High.
13. Overall methodological judgement
Supports the safety note.
| Multidimensional assessment | |
|---|---|
| Authenticity of the source | verified |
| Methodological quality | moderate |
| Risk of bias | some concerns |
| Precision of results | moderate |
| Directness | indirect |
| Reproducibility | partly replicated |
| Consistency with the overall evidence | consistent |
| Regional transferability | high |
| Adequacy of the interpretation (by the archive) | not applicable |
14. Open questions
Effect of adherence directly.
15. Linked fact checks
- In a joint live stream on Elawady's channel, a speaker (Elawady or his guest Dr. Tamer El-Baz; speaker turns cannot be identified) describes a coeliac patient on the system who reintroduced gluten-containing toast, and advises pausing it when symptoms appear and reintroducing it later. – Studies contradicting or limiting the claim